Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Investigation and prediction on resistance of infantile hemangioma in midanaphase of propranolol treatment
ChiCTR-IPR-16009281Phase 4Not yet recruiting
- Sponsor
- Shanghai Ninth People's Hospital
- Start
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of propranolol in Capillary Haemangioma (2 arms), sponsored by Shanghai Ninth People's Hospital. Primary endpoint: Residual lesion rate. Planned start Oct 2016; status: not yet recruiting.
02
Drugs
propranolol
03
Conditions
Capillary Haemangioma
Beyond the preview
Go deeper on ChiCTR-IPR-16009281.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-16009281.